Articles From This Issue
UP FRONT
Chief Medical Editor's Page
The Hard Truth About Innovation
By Iqbal Ike K. Ahmed, MD, FRCSC
The path of innovation is not a straight line. It can certainly look that way in retrospect and from the outside. But those in the trenches learn that setbacks are a diff...
THE LITERATURE
Quality of Life for Glaucoma Patients
By Stephen Walters, MD; and Lama Al-Aswad, MD, MPH
Factors Associated With Health-Related Quality of Life in Medically and Surgically Treated Patients With Glaucoma...
Lifestyle Modifications
By Jordan Stanley, MD; and Leonard K. Seibold, MD
Patients often ask, “Is there anything else I can do?”
Supplements and CME
CME - 1 Credit
New Treatments for Open-Angle Glaucoma and Ocular Hypertension: An Update on New Therapeutic Options (Part 1 of 2)
This educational activity was made possible in part by a grant from Bausch + Lomb.
Nathan Radcliffe, MD, Moderator; Ben Gaddie, OD; Louis Pasquale, MD
NEWS
EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pil…
EyeGate Pharmaceuticals announced that it has submitted an amended Investigational Device Exemption …
Icon Bioscience Receives FDA Approval for Dexycu Drug Therapy for Treating Infla…
Icon Bioscience announced that the FDA has approved the company's new drug application for Dexyc…
EyeGate Announces Topline Results for Phase 2b Trial of EGP-437 in Cataract Surg…
EyeGate Pharmaceuticals announced topline results from a phase 2b study of EGP-437 combination produ…
Patients Are Going Blind Due to 6-Month Waiting Lists for Cataract Surgery
Patients face going blind while waiting for cataract surgery after new figures showed waiting times …
Featured Content
